Marker Therapeutics, Inc.MRKRNASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-10.91M
↑ 35% above average
Average (9y)
$-16.66M
Historical baseline
Range
High:$-4.34M
Low:$-30.41M
CAGR
+10.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-10.91M | +33.6% |
| 2023 | $-16.44M | +39.0% |
| 2022 | $-26.97M | +11.3% |
| 2021 | $-30.41M | -3.8% |
| 2020 | $-29.29M | -57.0% |
| 2019 | $-18.66M | -27.6% |
| 2018 | $-14.63M | -73.3% |
| 2017 | $-8.44M | -29.6% |
| 2016 | $-6.51M | -49.9% |
| 2015 | $-4.34M | - |